Candela's Vbeam laser approved in Japan
This article was originally published in Clinica
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Candela Corporation's Vbeam laser system for the treatment of vascular conditions. The company, a subsidiary of Syneron Medical, claims that the technology is the first and only long pulsed dye laser system to be approved in Japan. The device can be used to treat vascular lesions such as rosacea, facial and leg veins, and haemangioma, a benign tumour caused by an abnormal build up of blood vessels. It can also be used for aesthetic procedures such as removal of sun spots, wrinkles, stretch marks and warts. The laser delivers energy to patients' underlying blood vessels but does not affect superficial skin layers, the Wayland, Massachusetts firm says.